Department of Pharmacology, Gulhane Academy of Medicine, 06010, Ankara, Turkey.
Eur J Pharmacol. 2012 Feb 29;677(1-3):93-101. doi: 10.1016/j.ejphar.2011.12.016. Epub 2011 Dec 21.
Although some studies have shown the essential role of descending serotonergic pathways and spinal 5-HT(1A), 5-HT(2A), or 5-HT(3) receptors in the antinociceptive effects of paracetamol, other studies have presented conflicting results, and the particular subtype of spinal 5-HT receptors involved in paracetamol-induced analgesia remains to be clarified. Recent studies have demonstrated the importance of spinal 5-HT(7) receptors in descending serotonergic pain inhibitory pathways. In this study, we investigated the role of descending serotonergic pathways and spinal 5-HT(7) receptors compared with 5-HT(3) and 5-HT(2A) receptors in the antinociceptive and antihyperalgesic effects of paracetamol. Tail-flick, hot plate and plantar incision tests were used to determine nociception in male BALB/c mice. Lesion of serotonergic bulbospinal pathways was performed by intrathecal (i.th.) injection of 5,7-dihydroxytryptamine (5,7-DHT), and spinal 5-HT levels were measured by HPLC. To evaluate the particular subtypes of the spinal 5-HT receptors, the selective 5-HT(7), 5-HT(3) and 5-HT(2A) receptor antagonists SB 269970, ondansetron and ketanserin, respectively, were given i.th. after oral administration of paracetamol. Oral paracetamol (200, 400 and 600 mg/kg) elicits dose-dependent antinociceptive and antihyperalgesic effects. I.th. pretreatment with 5,7-DHT (50 μg) sharply reduced 5-HT levels in the spinal cord. Depletion of spinal 5-HT totally abolished the antinociceptive and antihyperalgesic effects of paracetamol. I.th. injection of SB 2669970 (10 μg) blocked the antinociceptive and antihyperalgesic effects of paracetamol, but ondansetron and ketanserin (10 μg) did not. Our findings suggest that systemic administration of paracetamol may activate descending serotonergic pathways and spinal 5-HT(7) receptors to produce a central antinociceptive and antihyperalgesic effects.
尽管一些研究表明下行 5-羟色胺能通路和脊髓 5-HT(1A)、5-HT(2A)或 5-HT(3)受体在扑热息痛的镇痛作用中起重要作用,但其他研究结果却存在冲突,而涉及扑热息痛诱导镇痛的脊髓 5-HT 受体的特定亚型仍有待阐明。最近的研究表明,脊髓 5-HT(7)受体在下行 5-羟色胺能疼痛抑制通路上具有重要作用。在这项研究中,我们研究了与 5-HT(3)和 5-HT(2A)受体相比,下行 5-羟色胺能通路和脊髓 5-HT(7)受体在扑热息痛的镇痛和抗痛觉过敏作用中的作用。尾巴敲击、热板和足底切口试验用于测定雄性 BALB/c 小鼠的疼痛。通过鞘内(i.th.)注射 5,7-二羟基色胺(5,7-DHT)破坏 5-羟色胺的球脊髓途径,并通过 HPLC 测量脊髓 5-HT 水平。为了评估脊髓 5-HT 受体的特定亚型,选择性 5-HT(7)、5-HT(3)和 5-HT(2A)受体拮抗剂 SB 269970、昂丹司琼和酮色林分别在口服扑热息痛后鞘内给予。口服扑热息痛(200、400 和 600mg/kg)引起剂量依赖性镇痛和抗痛觉过敏作用。i.th. 预处理 5,7-DHT(50μg)可显著降低脊髓中的 5-HT 水平。脊髓 5-HT 的耗竭完全消除了扑热息痛的镇痛和抗痛觉过敏作用。i.th. 注射 SB 2669970(10μg)阻断了扑热息痛的镇痛和抗痛觉过敏作用,但昂丹司琼和酮色林(10μg)没有。我们的发现表明,系统给予扑热息痛可能激活下行 5-羟色胺能通路和脊髓 5-HT(7)受体,从而产生中枢性镇痛和抗痛觉过敏作用。